Daniel H. Movens, president of Anda, Inc., a wholly owned subsidiary of Andrx Corporation, has been named the new CEO and appointed a director of Caraco Pharmaceutical Laboratories, Ltd., effective May 2, 2005.

"We are delighted to have Dan join our Company and lead our team," Dilip Shanghvi, chairman of the Board of Caraco said adding, "Dan brings a wealth of leadership and experience to Caraco, as well as a strong record of past success at Anda, Inc. During his tenure at Anda, Inc., the business grew from $50 million to over $700 million in total sales revenue. We are confident that Dan is the right person at the right time to significantly grow our business."

Detroit-based Caraco Pharmaceutical Laboratories, Ltd., develops, manufactures and distributes generic and private-label prescription drugs to some of the nation's largest wholesalers, distributors, drugstore chains, healthcare systems and state and federal agencies.